• Psychiatry
    • Professor at Department of Psychology, University of Pittsburgh
    Dr. Donny is a Professor of Psychology (primary), Psychiatry and Behavioral & Community Health Sciences at the University of Pittsburgh. His expertise includes behavioral pharmacology, biological and health psychology, addiction, and regulatory science. His research has included a wide range of topics and techniques including animal models of self-administration, human abuse liability of cocaine and heroin, functional neuroimaging, population-based surveys, and clinical trials of tobacco products. His current interests focus on regulatory approaches to reducing the health burden of tobacco. He co-directs the Center for the Evaluation of Nicotine in Cigarettes (CENIC), an NIDA/FDA-funded cooperative agreement involving 12 institutions that aims to increase understanding of how behavior and health might be affected in the vast majority of smokers who are either unable or unwilling to quit, if the nicotine content of combustible tobacco products is reduced.
  • Jennifer Tidey is an Associate Professor (Research) of Psychiatry and Human Behavior and of Behavioral and Social Sciences at Brown University. She is a core faculty member of Brown's Center for Alcohol and Addictions Studies (CAAS), Director of the CAAS Addictive Behaviors Laboratory and Associate Director of the training program. She is an Associate Editor for the journals Nicotine & Tobacco Research and Tobacco Regulatory Science, and a member of the Board of Directors for the College on Problems of Drug Dependence. Trained as a behavioral pharmacologist at Tufts University, Dr. Tidey completed post-graduate training at Harvard University and the University of Vermont before coming to Brown in 1999. The twin goals of her research are to identify mechanisms underlying the high rates of cigarette smoking in people with serious mental illness, and to develop effective smoking treatments for these patients. She currently conducts research in the high-impact area of tobacco regulatory science, the aim of which to provide the FDA with the science it needs to make regulatory decisions about cigarettes and other tobacco products.
  • Director of the Tobacco Research Programs, University of Minnesota
    Director of the Tobacco Research Programs, University of Minnesota
    • Professor of Psychiatry at University of Minnesota
    Dorothy K. Hatsukami, Ph.D. holds the Forster Family Chair in Cancer Prevention at the Masonic Cancer Center of the University of Minnesota and is Professor of Psychiatry. She is the Associate Director of Cancer Prevention and Control at the University of Minnesota Masonic Cancer Center and Director of the Tobacco Research Programs. She has published extensively in the area s of nicotine addiction, tobacco product evaluation and methods to reduce tobacco harm and has received support from the National Institute on Drug Abuse and the National Cancer Institute to support her research. She has contributed to several Surgeon General’s Reports on the topic of nicotine addiction. She has served on numerous scientific advisory boards for the U.S. government including the Food and Drug Administration, Tobacco Product Scientific Advisory Committee, National Advisory Council on Drug Abuse, Interagency Committee on Smoking and Health, Substance Abuse and Mental Heal Services Administration, Scientific Board of Counselors for the National Institutes on Drug Abuse, and the Drug Control Research, Data and Evaluation Committee of the Office on National Drug Control Policy. She is currently a member of the World Health Organization Study Group on Tobacco Product Regulation. She has served as President of two scientific organizations, the Society for Research on Nicotine and Tobacco and the College on Problems of Drug Dependence. Dr. Hatsukami received her doctorate in clinical psychology at the University of Minnesota.
    • Internal Medicine
    • Professor of Medicine at UCSF School of Medicine
    Neal Benowitz has been conducting research at SFGH since 1973. His research focus is on the human pharmacology of nicotine in relation to pathogenesis of and individual differences in vulnerability to tobacco-related disease, and the use of pharmacologic data as a basis for public health policies to prevent and reduce such disease. He has served on a number of national and international committees addressing issues in tobacco-related diseases and smoking cessation, including several sponsored by the Institute of Medicine. He has authored over 500 publications, including a state-of-the-art review on nicotine addiction in the New England Journal of Medicine in June 2010.
    • Preventive Medicine
    • Health Policy
    Michael Fiore, University of Wisconsin Hilldale Professor of Medicine, founded and has served as Director of the University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI) since it was established in 1992. He is a clinically active general internist and preventive medicine specialist, treating patients for tobacco dependence. Dr. Fiore is a nationally recognized expert on tobacco, providing perspectives to audiences ranging from Good Morning America to the United States Senate. He has written numerous articles, chapters, and books on cigarette smoking and was a consulting editor of Reducing Tobacco Use—A Report of the Surgeon General (2000). Fiore served as chair of the panel that produced the United States Public Health Service (PHS) Clinical Practice Guideline: Treating Tobacco Use and Dependence, in 2000 which provides a gold standard for healthcare providers. That PHS Guideline was updated and published in 2008 with the simultaneous endorsement of 58 leading medical and public health organizations. He co-directed The Robert Wood Johnson Foundation National Program Offices, Addressing Tobacco in Managed Care and Addressing Tobacco in Healthcare Research Network. He is the recipient of numerous awards and honors, including Bowdoin College’s Common Good Award, the Institute of Medicine as a Profession (IMAP) Physician Advocacy Merit Award, and election to the Association of American Physicians. In 2012, he was elected to the National Academy of Medicine (formerly, Institute of Medicine). Dr. Fiore chaired the U.S. Department of Health and Human Services Subcommittee on Tobacco Cessation of the Interagency Committee on Smoking and Health that produced a comprehensive plan for promoting tobacco cessation in the United States. In July 2003, he was one of five national recipients of the Innovators in Combating Substance Abuse Award from the Robert Wood Johnson Foundation. In 2005, Dr. Fiore was asked by the United States Justice Department as part of their landmark lawsuit against the tobacco industry to craft a $130 billion, 25-year plan to assist 33 million smokers to quit. Fiore’s chief research and policy focus has been to develop strategies to prompt clinicians and health care systems to intervene with patients who use tobacco. As part of this effort, he spearheaded the concept of expanding the vital signs to include tobacco use status. Recent research shows that 70 percent of patients visiting healthcare settings are asked about their smoking status. In total he has authored over 200 scientific publications. Starting in 1999, Dr. Fiore was principal investigator for a five-year NIH-funded Transdisciplinary Tobacco Use Research Center (TTURC) grant designed to understand tobacco dependence in order to prevent relapse to smoking. In September, 2004, he began his role as co-principal investigator of a second TTURC grant, seeking to examine tobacco dependence treatment and outcomes with an eye to determining the effectiveness of various treatments and matching those treatments to smokers wishing to quit. In September 2009, he began serving as principal investigator for the third NIH/NCI P50 grant awarded to UW-CTRI, Engineering Effective Interventions for Tobacco Use: A Translational Laboratory. In September 2014, the NIH/NCI awarded UW-CTRI its fourth center grant (PO1) Optimized Chronic Care for Smokers: A Comparative Effectiveness Approach, with Drs. Fiore and Baker as PIs. After graduating from Bowdoin College, Dr. Fiore completed medical school at Northwestern University in Chicago and his internal medicine training at Boston City Hospital. His postgraduate education included a Masters of Public Health from Harvard University. Dr. Fiore received additional training as an Epidemic Intelligence Service (EIS) Officer for the United States Centers for Disease Control where he also completed a Preventive Medicine residency program at the United States Office on Smoking and Health before coming to the University of Wisconsin-Madison. In 2009, Dr. Fiore earned an MBA from the University of Wisconsin School of Business.
Powered by Medstro